Patent details

EP3250610 Title: FCRN ANTIBODIES AND METHODS OF USE THEREOF

Basic Information

Publication number:
EP3250610
PCT Application Number:
US2016015720
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167442045
PCT Publication Number:
WO2016123521
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FCRN ANTIBODIES AND METHODS OF USE THEREOF
French Title of Invention:
ANTICORPS FCRN ET LEURS PROCÉDÉS D'UTILISATION
German Title of Invention:
FCRN-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVON
SPC Number:

Dates

Filing date:
29/01/2016
Grant date:
09/08/2023
EP Publication Date:
06/12/2017
PCT Publication Date:
04/08/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/08/2023
EP B1 Publication Date:
09/08/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/01/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/08/2023
 
 

Name:
Momenta Pharmaceuticals, Inc.
Address:
1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/08/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KEHRY, Marilyn
Address:
United States (US)

2

Name:
KING, David, J.
Address:
United States (US)

3

Name:
MANNING, Anthony
Address:
United States (US)

4

Name:
LING, Leona, E.
Address:
United States (US)

5

Name:
MEADOR, James III
Address:
United States (US)

6

Name:
ROY, Sucharita
Address:
United States (US)

Priority

1

Priority Number:
201562110071 P
Priority Date:
30/01/2015
Priority Country:
United States (US)

2

Priority Number:
201562258082 P
Priority Date:
20/11/2015
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; G01N 33/68; A61P 35/00; A61P 37/00;

Publication

European Patent Bulletin

1

Issue number:
202332
Publication date:
09/08/2023
Description:
Grant (B1)

2

Issue number:
202337
Publication date:
13/09/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/01/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
14/08/2023 Power Of Attorney 1
14/08/2023 Outgoing Correspondence 1